In order to enhance MHC I melanoma antigen presentation, B16BL6 derived melanoma exosomes can be modified with GALA (Glu-Ala-Leu-Ala), a pH-sensitive fusogenic peptide. The gene discussed is GLA; the disease is melanoma.